House Bill 2074
116th Congress(2019-2020)
Gluten in Medicine Disclosure Act of 2019
Introduced
Introduced in House on Apr 3, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2074
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Gluten in Medicine Disclosure Act of 2019
This bill prohibits the sale of any drug intended for human use that contains an ingredient derived from a gluten-containing grain unless the drug's label (1)states that the drug contains such an ingredient, and (2)identifies the type of grain from which the ingredient is derived.
April 3, 2019
Sort by most recent
04/04/2019
Referred to the Subcommittee on Health.
04/03/2019
Referred to the House Committee on Energy and Commerce.
04/03/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 7:02:22 PM